Realty Income (NYSE:O – Free Report) had its price objective cut by Royal Bank of Canada from $67.00 to $63.00 in a report published on Wednesday morning,Benzinga reports. They currently have an outperform rating on the real estate investment trust’s stock. O has been the topic of several other research reports. UBS Group raised their […]

NIKE (NYSE:NKE – Get Free Report) had its price objective cut by analysts at Royal Bank of Canada from $82.00 to $80.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “sector perform” rating on the footwear maker’s stock. Royal Bank of Canada’s price target indicates a potential upside of […]

Verve Therapeutics (NASDAQ:VERV – Free Report) had its price target trimmed by Royal Bank of Canada from $20.00 to $17.00 in a research note released on Wednesday, Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts have also weighed in on the company. HC Wainwright decreased their […]

uniQure (NASDAQ:QURE – Get Free Report) had its price objective dropped by equities researchers at Royal Bank of Canada from $16.00 to $14.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank of Canada’s target price would […]

Adverum Biotechnologies (NASDAQ:ADVM – Free Report) had its target price reduced by Royal Bank of Canada from $12.00 to $10.00 in a report released on Tuesday, Benzinga reports. They currently have a sector perform rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the company. Truist Financial […]